Share your internal medicine pride by posting about National Internal Medicine Day on social media and joining a Twitter chat at 8 p.m. ET on Oct. 28.
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
A 67-year-old man is evaluated in follow-up for urinary incontinence. Six months ago, he began tamsulosin for occasional nocturia, frequency, and urgency related to benign prostatic hyperplasia. Tamsulosin decreased the frequency of nocturia, but he continued to have daytime urinary urgency with a few occasions of urine leakage. Following a physical exam and bladder ultrasonography, what is the most appropriate treatment?
High-risk patients had similar knee function and pain at one year whether they received weekly sessions with a physiotherapist or were assigned to a home exercise program, according to a U.K. trial.
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
The list of winners is available on ACP Online.